Weekly dosing charts, by objective.

Every schedule is grounded in a published trial or preclinical paper. Reconstitution math, syringe draw volumes and cycle length included.

BPC-157 + TB-500 protocol

Recovery & Tissue Repair

The most-researched combination for soft-tissue, tendon and ligament recovery studies. Sourced from preclinical literature (Sikiric 2018, Goldstein 2015).

4–6 weeks per research cycleView protocol

Semaglutide / Tirzepatide

GLP-1 Metabolic Research

Weekly-dosed protocols for GLP-1 and GIP receptor studies. Reconstitution math and dose escalation follow SURMOUNT / SURPASS / STEP trial designs.

12–52 weeks depending on study endpointsView protocol

Sermorelin / Tesamorelin / Ipamorelin

Growth Hormone Research

GHRH-analog and selective secretagogue protocols for growth-hormone axis research, drawing from published Sermorelin and Tesamorelin trial designs.

8–16 weeks per research cycleView protocol

Epithalon + MOTS-c + NAD+

Longevity & Cellular Energy

Multi-target longevity protocol drawing from telomerase (Epithalon), mitochondrial-derived peptide (MOTS-c) and NAD+ precursor research.

10-day cycles, 3–6 month intervalsView protocol